1.24
                                            
            Painreform Ltd stock is traded at $1.24, with a volume of 48,281.
            It is up +3.33% in the last 24 hours and down -11.43% over the past month.
            PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
        
        See More
    Previous Close:
              $1.20
            Open:
              $1.22
            24h Volume:
                48,281
            Relative Volume:
              0.02
            Market Cap:
                $2.50M
            Revenue:
              -
            Net Income/Loss:
              $-9.34M
            P/E Ratio:
              -0.1737
            EPS:
                -7.14
            Net Cash Flow:
                $-6.69M
            1W Performance:
              -4.98%
            1M Performance:
              -11.43%
            6M Performance:
                -48.76%
            1Y Performance:
              -38.00%
            Painreform Ltd Stock (PRFX) Company Profile
Compare PRFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                PRFX
                            
                             Painreform Ltd | 1.24 | 2.42M | 0 | -9.34M | -6.69M | -7.14 | 
|   
                          
                                ZTS
                            
                             Zoetis Inc | 144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
|   
                          
                                TAK
                            
                             Takeda Pharmaceutical Co Adr | 13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 | 
|   
                          
                                HLN
                            
                             Haleon Plc Adr | 9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 | 
|   
                          
                                TEVA
                            
                             Teva Pharmaceutical Industries Ltd Adr | 20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 | 
|   
                          
                                UTHR
                            
                             United Therapeutics Corp | 445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 | 
Painreform Ltd Stock (PRFX) Latest News
What drives PainReform Ltd stock pricePrice Support Zones & Double Digit Returns - earlytimes.in
Why PainReform Ltd. stock could rally in 20252025 Breakouts & Breakdowns & Risk Controlled Stock Alerts - newser.com
Is PainReform Ltd. stock cheap at current valuation2025 Year in Review & Stock Portfolio Risk Control - newser.com
Best data tools to analyze PainReform Ltd. stock2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Price momentum metrics for PainReform Ltd. explainedMarket Movers & Accurate Buy Signal Notifications - newser.com
Will PainReform Ltd. bounce back from current support2025 Breakouts & Breakdowns & High Conviction Trade Alerts - newser.com
How PainReform Ltd. stock compares to industry benchmarks2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Regression analysis insights on PainReform Ltd. performanceTrade Ideas & Scalable Portfolio Growth Methods - newser.com
Is PainReform Ltd. stock attractive for long term wealth buildingEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Published on: 2025-10-28 00:12:36 - newser.com
Risk Analysis: Will PainReform Ltd. stock sustain high P E ratios2025 Year in Review & Growth Focused Entry Reports - Fundação Cultural do Pará
Published on: 2025-10-26 10:37:40 - newser.com
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App